rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kush Parmar

Director

Company insider

Files Form 4 as: 10% owner, Skye Bioscience; Director and 10% owner, Entrada Therapeutics; Director and 10% owner, Rallybio; Director and 10% owner, Akouos; Director and 10% owner, Leverage Shares 2X Long FIX Daily ETF; Director and 10% owner, Vor Biopharma; 10% owner, CinCor Pharma; 10% owner, Impel Neuropharma.

Every Form 4 they filed

In numbers

Trades disclosed
142
Buys
7
Sells
23
Bought
$48.6M
Sold
$64.3M
Companies
12
Companies where not an officer
11
First trade
24 Aug 2016
Last trade
16 Sep 2026
Last filed
18 Sep 2026

Companies traded

Where they are an officer
5:01 AcquisitionDirector, Officer, 10% owner · last 30 Nov 20200 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SKYE Skye Bioscience10% owner · Biotechnology · last 16 Sep 20261 buy · 1 sell
TRDA Entrada TherapeuticsDirector, 10% owner · Biotechnology · last 10 Aug 20261 buy · 10 sells
RLYB RallybioDirector, 10% owner · Biotechnology · last 15 May 20241 buy · 4 sells
AkouosDirector, 10% owner · last 1 Dec 20221 buy · 1 sell
FIXX Leverage Shares 2X Long FIX Daily ETFDirector, 10% owner · last 15 Jun 20220 buys · 6 sells
VOR Vor BiopharmaDirector, 10% owner · Biotechnology · last 14 Jun 20221 buy · 1 sell
CinCor Pharma10% owner · last 11 Jan 20221 buy · 0 sells
Impel Neuropharma10% owner · last 27 Apr 20211 buy · 0 sells
ARVN ArvinasDirector · Biotechnology · last 24 Sep 20190 buys · 0 sells
scPharmaceuticalsDirector · last 19 Jun 20180 buys · 0 sells
Audentes TherapeuticsDirector · last 8 Jun 20180 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Sep 2026filed 18 Sep 2026SKYE Skye BioscienceBiotechnologySEC FORM 4 Sold$62K32,607 at $1.91filing
16 Sep 2026filed 18 Sep 2026SKYE Skye BioscienceBiotechnologySEC FORM 4 Sold$2,4541,285 at $1.91filing
10 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$647K92,444 at $7.00filing
10 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$647K92,444 at $7.00filing
7 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$358K52,317 at $6.85filing
7 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$358K52,317 at $6.85filing
6 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$73K10,494 at $7.00filing
6 Aug 2026filed 10 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$73K10,494 at $7.00filing
31 Jul 2026filed 3 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$12K1,718 at $6.85filing
31 Jul 2026filed 3 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$12K1,718 at $6.85filing
30 Jul 2026filed 3 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$795K114,756 at $6.93filing
30 Jul 2026filed 3 Aug 2026TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$795K114,756 at $6.93filing
10 Jun 2026filed 12 Jun 2026TRDA Entrada Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,000 at $0.00filing
10 Jun 2026filed 12 Jun 2026TRDA Entrada Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,000 at $0.00filing
14 Nov 2025filed 18 Nov 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$1.8M200,000 at $8.80filing
9 Jul 2025filed 11 Jul 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$150K20,065 at $7.50filing
9 Jul 2025filed 11 Jul 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$52K6,935 at $7.50filing
1 Jul 2025filed 1 Jul 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$132K18,578 at $7.12filing
1 Jul 2025filed 1 Jul 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$46K6,422 at $7.12filing
30 Jun 2025filed 1 Jul 2025TRDA Entrada TherapeuticsBiotechnologySEC FORM 4 Sold$127K18,578 at $6.81filing

Sectors

Health Care20
Not placed10

Buys in green, sells in red, by the company’s sector.

Related people

5AM Partners VII, LLC10% owner · Also traded SKYE in the last 90 days
Andrew J. SchwabDirector and 10% owner · Also traded SKYE in the last 90 days
MPM BioVentures 2014, L.P.10% owner · Also traded TRDA in the last 90 days
MPM BIOVENTURES 2018, L.P.10% owner · Also traded TRDA in the last 90 days
5AM Ventures V, L.P.10% owner · Also traded TRDA in the last 90 days